(Q43760328)

26 November 2017

Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer (English)

1 reference

microvasculature remodeling

26 November 2017

1 reference

1 reference

1

1 reference

26 November 2017

6

1 reference

26 November 2017

Taylor M

2

1 reference

26 November 2017

Grøndahl-Hansen J

series ordinal

3

1 reference

26 November 2017

Kakolyris S

series ordinal

4

1 reference

26 November 2017

Gatter KC

series ordinal

5

1 reference

26 November 2017

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

195

1 reference

26 November 2017

236-243

1 reference

26 November 2017

2

1 reference

The urokinase receptor: involvement in cell surface proteolysis and cancer invasion

26 November 2017

1 reference

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

21 January 2018

1 reference

The urokinase-type plasminogen activator system in cancer metastasis: a review

21 January 2018

1 reference

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis

21 January 2018

1 reference

Upregulation of urokinase receptor expression on migrating endothelial cells

21 January 2018

1 reference

Tumour angiogenesis and prognosis.

21 January 2018

1 reference

Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells

21 January 2018

1 reference

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

21 January 2018

1 reference

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

21 January 2018

1 reference

JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections

21 January 2018

1 reference

The distribution of LH39 basement membrane epitope in the tumour stroma of oral squamous cell carcinomas.

21 January 2018

1 reference

A novel lamina lucida component of epithelial and endothelial basement membranes detected by LH39 monoclonal antibody

21 January 2018

1 reference

Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39.

21 January 2018

1 reference

The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium

21 January 2018

1 reference

Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours

21 January 2018

1 reference

Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer

21 January 2018

1 reference

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

21 January 2018

1 reference

Urokinase and macrophages in tumour angiogenesis

21 January 2018

1 reference

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

21 January 2018

1 reference

Thymidine phosphorylase is angiogenic and promotes tumor growth.

21 January 2018

1 reference

Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition

21 January 2018

1 reference

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.

21 January 2018

1 reference

Prognostic value of urokinase plasminogen activator in primary breast carcinoma: comparison of two immunoassay methods

21 January 2018

1 reference

Plasminogen activator inhibitor-1 and prognosis in primary breast cancer

21 January 2018

1 reference

Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer

21 January 2018

1 reference

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

21 January 2018

1 reference

Tumor angiogenesis in node-negative breast carcinomas ? relationship with epidermal growth factor receptor, estrogen receptor, and survival

21 January 2018

1 reference

Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study

21 January 2018

1 reference

Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF

21 January 2018

1 reference

Plasminogen activators (urokinase) mediate neovascularization: possible role in tumor angiogenesis

21 January 2018

1 reference

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

21 January 2018

1 reference

Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer

21 January 2018

1 reference

Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues

21 January 2018

1 reference

Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues

21 January 2018

1 reference

Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine

21 January 2018

1 reference

Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression

21 January 2018

1 reference

Prognostic significance of PAI-1 and uPA in cytosolic extracts obtained from node-positive breast cancer patients

21 January 2018

1 reference

Urokinase-type plasminogen activator antigen and early relapse in breast cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.931

1 reference

26 November 2017

1 reference